Fig. 1: Patient disposition according to JGL4.

COPD chronic obstructive pulmonary disease, FDC fixed-dose combination, ICS inhaled corticosteroid, JGL Japanese asthma guidelines, LABA long-acting β2-agonist.
COPD chronic obstructive pulmonary disease, FDC fixed-dose combination, ICS inhaled corticosteroid, JGL Japanese asthma guidelines, LABA long-acting β2-agonist.